View More Recent Stories

Mar 16, 2023 03:05AM Evotec Announces Progress in Strategic Protein Degradation Partnership with Bristol Myers Squibb
Feb 9, 2023 02:00AM Evotec and Related Sciences Expand Integrated Drug Discovery and Development Partnership
Dec 6, 2022 07:00AM Exscientia Presents Novel Immuno-Oncology Biomarker for EXS-21546 at the ESMO I-O Annual Congress
Nov 28, 2022 07:01AM Exscientia plc (EXAI) Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
Nov 28, 2022 07:00AM Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
Nov 3, 2022 03:00AM Evotec Completes Acquisition of Central Glass Germany
Oct 28, 2022 03:20AM Evotec, CDP Venture Capital and Angelini Ventures Launch Translational Partnership 'Extend' with Leading Italian Academic Institutions
Oct 18, 2022 02:00AM Evotec launches PanOmics Data Analysis Platform PanHunter at Bio-IT World
Oct 17, 2022 07:00AM TIAP and Evotec Expand LAB150 BRIDGE Partnership to Include Amgen
Sep 21, 2022 06:02AM Evotec SE (EVO) Enters Collaboration with Adapsyn
Sep 21, 2022 06:00AM Adapsyn Bioscience enters into strategic collaboration with Evotec
Sep 20, 2022 01:50AM Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense Under Accelerated Antibodies Program
Aug 10, 2022 05:02AM Alpine Immune Sciences (ALPN) and Evotec (EVO) Expand Partnership for Development of ALPN-303
Aug 10, 2022 01:30AM Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
Jun 14, 2022 08:04AM Exscientia plc (EXAI) Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers
Jun 14, 2022 08:00AM Exscientia Reports Topline Data From EXS-21546 Phase 1a Study Demonstrating Targeted A2A Receptor Signaling Inhibition in Healthy Volunteers
Jun 14, 2022 01:50AM Evotec Enters a Drug Discovery Collaboration with Janssen
May 19, 2022 05:42AM Evotec SE (EVO) and Almirall Enter Multi-Target Alliance in Medical Dermatology
May 19, 2022 01:50AM Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology
Apr 5, 2022 08:55AM Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022
Jan 3, 2022 05:48AM Evotec SE (EVO) Announces EUR 7.5M Grant for Development of COVID-19 Therapeutic
Jan 3, 2022 01:55AM Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
Nov 18, 2021 07:00AM EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership
Jun 16, 2021 09:16AM Bitstarz - The first online casino to accept Bitcoin
Jun 1, 2021 08:14AM Trustworthy live online Casino sites with Live Dealers UK
View More Recent Stories